Pune, India -- (SBWIRE) -- 01/19/2018 -- The Global Anatomic Pathology Market accounted to USD 16.5 billion in 2016 growing at a CAGR of 6.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Market Definition: Global Anatomic Pathology Market

Anatomic pathology is a medical specialty that is required in the diagnosis of disease based on the microscopic, macroscopic, biochemical, immunologic and molecular examination of organs and tissues. In the last few years, surgical pathology has evolved extremely, from ancient examination of whole bodies (autopsy) to modern techniques needed for the diagnosis and prognosis of cancer to guide treatment decision-making in oncology.

Get Free Sample Copy of the Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-anatomic-pathology-market  

Major market drivers and restraints: Global Anatomic Pathology Market

- Increasing Incidence of Cancer

- Growing Healthcare Expenses

- Strict Government Regulations

- Rapid Growth in the Emerging Markets

- High Degree of Consolidation

Market Segmentation: Global Anatomic Pathology Market



- On the basis of type, global anatomic pathology market is segmented into instruments, consumables and services.

- Instruments are again sub-segmented into tissue processing systems, slide staining systems, microtomes, and others.

- Consumables are again sub-segmented into antibodies & reagents, kits, probes, and others.

- Services are again sub-segmented into cytopathology, histopathology, and others.

- On the basis of application the global anatomic pathology market is segmented into diseases diagnosis, drug discovery & development, and others.

- On the basis of end-users the global anatomic pathology market is segmented into hospitals, clinical laboratories, and physician office laboratory.

- On the basis of geography, global anatomic pathology market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.


Have Any Query? Ask Ours Expert @  http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-anatomic-pathology-market   

Competitive Analysis: Global Anatomic Pathology Market

The global anatomic pathology market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of anatomic pathology market for global, Europe, North America, Asia Pacific and South America.

Major Market Competitors: Global Anatomic Pathology Market

Some of the major players operating in global anatomic pathology market are F. Hoffmann-La Roche AG., Thermo Fisher Scientific, Inc., Koninklijke Philips N.V., Leica Microsystems, Digipath, Inc., Laboratory Corporation of America Holdings, Danaher, Angsana Molecular & Diagnostics Laboratory Pte Ltd, Quest Diagnostics Incorporated, Agilent Technologies, Sakura Finetechnical Co., Ltd., BioGenex, Bio SB, Neogenomics Laboratories, Inc., Nikon Corporation, Ventana Medical Systems, Inc., PerkinElmer, Inc., Definiens, Boston Scientific Corporation, Advanced Cell Diagnostics, Inc., Tecan Trading AG, RareCyte, Inc., Oxford Cancer Biomarkers, Enzo Biochem Inc., and Epic Sciences among others.

Follow Link for More Information @ http://databridgemarketresearch.com/reports/global-anatomic-pathology-market/